Style | Citing Format |
---|---|
MLA | Pazokitoroudi H, et al.. "Combination of Azelaic Acid 5% and Clindamycin 2% for the Treatment of Acne Vulgaris." Cutaneous and Ocular Toxicology, vol. 30, no. 4, 2011, pp. 286-291. |
APA | Pazokitoroudi H, Nilforoushzadeh MA, Ajami M, Jaffary F, Aboutaleb N, Nassirikashani M, Firooz A (2011). Combination of Azelaic Acid 5% and Clindamycin 2% for the Treatment of Acne Vulgaris. Cutaneous and Ocular Toxicology, 30(4), 286-291. |
Chicago | Pazokitoroudi H, Nilforoushzadeh MA, Ajami M, Jaffary F, Aboutaleb N, Nassirikashani M, Firooz A. "Combination of Azelaic Acid 5% and Clindamycin 2% for the Treatment of Acne Vulgaris." Cutaneous and Ocular Toxicology 30, no. 4 (2011): 286-291. |
Harvard | Pazokitoroudi H et al. (2011) 'Combination of Azelaic Acid 5% and Clindamycin 2% for the Treatment of Acne Vulgaris', Cutaneous and Ocular Toxicology, 30(4), pp. 286-291. |
Vancouver | Pazokitoroudi H, Nilforoushzadeh MA, Ajami M, Jaffary F, Aboutaleb N, Nassirikashani M, et al.. Combination of Azelaic Acid 5% and Clindamycin 2% for the Treatment of Acne Vulgaris. Cutaneous and Ocular Toxicology. 2011;30(4):286-291. |
BibTex | @article{ author = {Pazokitoroudi H and Nilforoushzadeh MA and Ajami M and Jaffary F and Aboutaleb N and Nassirikashani M and Firooz A}, title = {Combination of Azelaic Acid 5% and Clindamycin 2% for the Treatment of Acne Vulgaris}, journal = {Cutaneous and Ocular Toxicology}, volume = {30}, number = {4}, pages = {286-291}, year = {2011} } |
RIS | TY - JOUR AU - Pazokitoroudi H AU - Nilforoushzadeh MA AU - Ajami M AU - Jaffary F AU - Aboutaleb N AU - Nassirikashani M AU - Firooz A TI - Combination of Azelaic Acid 5% and Clindamycin 2% for the Treatment of Acne Vulgaris JO - Cutaneous and Ocular Toxicology VL - 30 IS - 4 SP - 286 EP - 291 PY - 2011 ER - |